FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- MEDNAX, Inc. (NYSE:MD) today announced that it has completed the acquisition of a neonatal group based in Arlington, Texas.

Arlington Neonatal Intensive Care, P.A., is a two-physician practice that staffs the Level III neonatal intensive care unit (NICU) at Texas Health Arlington Memorial Hospital, which has annual patient volume in excess of 5,000 NICU patient days.

The physicians will practice as part of MEDNAX’s Pediatrix Medical Group, a national medical group that encompasses the nation’s leading neonatal, maternal-fetal medicine and pediatric cardiology physician group practice.

“During the past 10 to 12 years I’ve been considering the decision to join Pediatrix, but the timing just hadn’t been right,” said Scott C. Tisdell, M.D., who has practiced neonatal medicine at Arlington Memorial since 1987 and who will continue to serve as Medical Director of the practice. “Today, our practice is growing, and it’s becoming more difficult for us to just be physicians. Pediatrix is well-known and well-respected in terms of its commitment of resources to physicians and I look forward to participating in some of those programs, such as clinical trials, that would lead to improved patient care.”

MEDNAX paid cash for the Arlington practice, which is expected to contribute immediately to the Company’s earnings. No additional terms of the transaction were disclosed.

About MEDNAX

MEDNAX, Inc., is a national medical group that comprises the nation’s leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 250 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric intensivist physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation’s largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 450 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,200 physicians in 32 states and Puerto Rico. Additional information is available at www.mednax.com.

Certain statements and information in this press release may be deemed to be “forward-looking statements” within the meaning of the Federal Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements (other than statements of historical facts) that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the Company’s most recent Annual Report on Form 10-K, including the section entitled “Risk Factors”.

Source: MEDNAX, Inc.

MEDNAX, Inc., Fort Lauderdale
Bob Kneeley, Director, Investor Relations, 954-384-0175 x-5300
bob_kneeley@mednax.com